Pitcairn’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Sell |
5,974
-726
| -11% | -$26.4K | 0.01% | 656 |
|
|
2025
Q1 | $243K | Sell |
6,700
-1,642
| -20% | -$59.5K | 0.01% | 644 |
|
|
2024
Q4 | $351K | Sell |
8,342
-2,242
| -21% | -$94.3K | 0.02% | 538 |
|
|
2024
Q3 | $588K | Sell |
10,584
-1,456
| -12% | -$80.9K | 0.03% | 385 |
|
|
2024
Q2 | $495K | Buy |
12,040
+4,083
| +51% | +$168K | 0.03% | 446 |
|
|
2024
Q1 | $372K | Sell |
7,957
-679
| -8% | -$31.7K | 0.02% | 516 |
|
|
2023
Q4 | $413K | Buy |
+8,636
| New | +$413K | 0.03% | 453 |
|